HKSE:01779 (China)
Â
Class H
HK$
113
+5.9 (+5.51%)
Aug 7
Business Description
Longbio Pharma (Suzhou) Co Ltd
ISIN : CNE100007NF2
Share Class Description:
HKSE:01779: Class HCompare
Compare
Traded in other countries / regions
01779.Hong Kong IPO Date
2026-06-05Description
Longbio Pharma (Suzhou) Co Ltd is a clinical-stage biotechnology company. The company and its subsidiaries are principally engaged in the research, development, manufacture and commercialisation of pharmaceutical products in the People's Republic of China (the PRC). It has developed a comprehensive product pipeline for biologic treatments targeting rhinology, dermatology, respiratory, hematology, nephrology and other autoimmune diseases, targeting allergic and autoimmune diseases. Its pipeline includes LP-003, LP-00A, LP-005, LP-00C, and LP-00D.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.04 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -0.25 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.42 | |||||
Quick Ratio | 2.42 | |||||
Cash Ratio | 2.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -94.53 | |||||
ROIC % | -161.31 | |||||
ROC (Joel Greenblatt) % | -997.74 | |||||
ROCE % | -161.58 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 54.02 | |||||
Price-to-Tangible-Book | 54.07 | |||||
EV-to-EBIT | -48.17 | |||||
EV-to-EBITDA | -50.59 | |||||
EV-to-FCF | -60.96 | |||||
| Price-to-Net-Current-Asset-Value | 66.08 | |||||
| Price-to-Net-Cash | 72.9 | |||||
Earnings Yield (Greenblatt) % | -2.08 | |||||
FCF Yield % | -1.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Longbio Pharma (Suzhou) Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | |||
| EPS (TTM) (HK$) | -2.614 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 58.06 | ||
| 14-Day ATR (HK$) | 10.900661 | ||
| 20-Day SMA (HK$) | 93.2575 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 72.65 - 165.9 | ||
| Shares Outstanding (Mil) | 76.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Longbio Pharma (Suzhou) Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Longbio Pharma (Suzhou) Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Longbio Pharma (Suzhou) Co Ltd Frequently Asked Questions
What is Longbio Pharma (Suzhou) Co Ltd(HKSE:01779)'s stock price today?
The current price of HKSE:01779 is HK$113.00. The 52 week high of HKSE:01779 is HK$165.90 and 52 week low is HK$72.65.
When is next earnings date of Longbio Pharma (Suzhou) Co Ltd(HKSE:01779)?
The next earnings date of Longbio Pharma (Suzhou) Co Ltd(HKSE:01779) is .
Does Longbio Pharma (Suzhou) Co Ltd(HKSE:01779) pay dividends? If so, how much?
Longbio Pharma (Suzhou) Co Ltd(HKSE:01779) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Longbio Pharma (Suzhou) Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers